[
  {
    "question": "The highest diagnostic yield for malignant pleural effusion is achieved by:",
    "options": {
      "A": "Pleural fluid cytology",
      "B": "Pleural fluid tumor markers",
      "C": "Medical thoracoscopy with biopsy",
      "D": "CT-guided pleural biopsy"
    },
    "correctAnswer": "C",
    "topic": "malignant_effusion",
    "deepDiveExplanation": "Medical thoracoscopy (pleuroscopy) with targeted biopsy offers the highest diagnostic yield for malignant pleural effusion, often exceeding 90-95%, especially in cases where initial pleural fluid cytology is negative. It allows direct visualization of the pleural surfaces and targeted biopsies of suspicious lesions. While cytology is often the first step, its sensitivity varies (around 60-70%) and can be lower for certain malignancies.",
    "highYieldPearl": "For undiagnosed exudative effusions with negative cytology, medical thoracoscopy is the preferred next diagnostic step due to its superior diagnostic yield.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Option A (cytology) is the initial test but has lower sensitivity. Option D (CT-guided biopsy) is more invasive and less comprehensive than thoracoscopy for pleural lesions. Thoracoscopy allows for broader sampling and visual assessment.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|malignant_effusion|Malignant Pleural Effusion|5_c9drsxqq"
  },
  {
    "question": "Among the following, the most effective pleurodesis agent for malignant pleural effusion is:",
    "options": {
      "A": "Doxycycline slurry",
      "B": "Bleomycin",
      "C": "Talc slurry",
      "D": "Povidone-iodine"
    },
    "correctAnswer": "C",
    "topic": "malignant_effusion",
    "deepDiveExplanation": "Talc slurry is widely considered the most effective and cost-efficient agent for pleurodesis in malignant pleural effusion, with success rates typically ranging from 70-90%. It induces inflammation and fibrosis, leading to fusion of the visceral and parietal pleura. Doxycycline, bleomycin, and povidone-iodine are alternative agents but generally have lower efficacy or higher costs compared to talc.",
    "highYieldPearl": "Talc pleurodesis, either as a slurry or poudrage, remains the gold standard for chemical pleurodesis due to its high efficacy and cost-effectiveness.",
    "examStyle": "NEET-SS",
    "difficulty": "Easy",
    "trapAnalysis": "All options are pleurodesis agents, but talc consistently shows superior efficacy in clinical trials and meta-analyses. Choosing any other agent would be incorrect as 'most effective' is specified.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|malignant_effusion|Malignant Pleural Effusion|5_ejsjysbm"
  },
  {
    "question": "Absolute contraindication for talc pleurodesis in malignant pleural effusion is:",
    "options": {
      "A": "Bilateral pleural effusions",
      "B": "Prior pleurodesis attempt",
      "C": "Trapped lung",
      "D": "Poor performance status"
    },
    "correctAnswer": "C",
    "topic": "malignant_effusion",
    "deepDiveExplanation": "Talc pleurodesis works by inducing inflammation and fibrosis that causes the visceral and parietal pleura to adhere. For this to be successful, the lung must be able to fully re-expand and appose the chest wall. A 'trapped lung' (non-expandable lung) prevents this apposition, rendering pleurodesis ineffective and potentially harmful. Other options like bilateral effusions or poor performance status might influence the decision for pleurodesis versus other management (e.g., IPC), but they are not absolute contraindications to the procedure itself if lung re-expansion is possible.",
    "highYieldPearl": "Successful pleurodesis hinges on complete lung re-expansion; a trapped lung makes it impossible and is an absolute contraindication.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Options A, B, D are relative considerations or challenges, but not absolute contraindications. A trapped lung means the fundamental mechanism of pleurodesis cannot occur, making it futile and potentially leading to complications without benefit.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|malignant_effusion|Malignant Pleural Effusion|5_3xm0mqsf"
  },
  {
    "question": "The primary mechanism for fluid accumulation in malignant pleural effusion is often:",
    "options": {
      "A": "Increased hydrostatic pressure",
      "B": "Decreased oncotic pressure",
      "C": "Impaired lymphatic drainage",
      "D": "Increased capillary permeability"
    },
    "correctAnswer": "C",
    "topic": "malignant_effusion",
    "deepDiveExplanation": "While multiple factors can contribute, the most common and significant mechanism in malignant pleural effusion is impaired lymphatic drainage. Tumor cells can obstruct the lymphatic stomata on the parietal pleura or metastasize to mediastinal lymph nodes, blocking the normal outflow of pleural fluid. Increased capillary permeability (due to inflammation) and increased hydrostatic pressure (due to venous obstruction) can also play a role, but lymphatic obstruction is paramount.",
    "highYieldPearl": "Think lymphatic obstruction as the cardinal mechanism behind MPE formation due to tumor involvement of lymphatic pathways.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Options A, B, D are mechanisms seen in other types of effusions (e.g., heart failure, hypoalbuminemia, inflammation), and can contribute to MPE, but lymphatic obstruction is the most specific and often primary driver in malignancy.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|malignant_effusion|Malignant Pleural Effusion|5_5nzog1qo"
  },
  {
    "question": "Which of the following is typically associated with a *low* pleural fluid Adenosine Deaminase (ADA) level?",
    "options": {
      "A": "Tuberculous pleurisy",
      "B": "Malignant pleural effusion",
      "C": "Empyema",
      "D": "Rheumatoid pleurisy"
    },
    "correctAnswer": "B",
    "topic": "malignant_effusion",
    "deepDiveExplanation": "Adenosine Deaminase (ADA) is an enzyme primarily released by lymphocytes. High pleural fluid ADA levels (typically >40-60 U/L) are highly suggestive of tuberculous pleurisy, which is characterized by a robust lymphocytic response. Empyema and parapneumonic effusions can also have elevated ADA due to inflammation and neutrophil activity, though usually not as high as TB. Malignant pleural effusions, while sometimes having mildly elevated ADA, are generally associated with lower ADA levels compared to infectious causes, making a low ADA value helpful in 'ruling out' TB or 'ruling in' MPE in the differential diagnosis.",
    "highYieldPearl": "A very low pleural fluid ADA (<10-20 U/L) makes tuberculous pleurisy highly unlikely, shifting the focus towards other causes like malignancy.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Options A and C are classic causes of *high* ADA. Option D can have variable ADA but is not typically considered 'low' compared to MPE. The key is understanding that MPE usually does not elicit the strong lymphocytic response that significantly elevates ADA, unlike TB.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|malignant_effusion|Malignant Pleural Effusion|5_05lvmx0a"
  }
]